INVEGA Trademark

Trademark Overview

On Thursday, July 26, 2007, a trademark application was filed for INVEGA with the United States Patent and Trademark Office. The USPTO has given the INVEGA trademark a serial number of 77239338. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, February 28, 2018. This trademark is owned by Johnson & Johnson. The INVEGA trademark is filed in the Pharmaceutical Products category with the following description:

human pharmaceutical for the treatment of Central Nervous System diseases
invega

General Information

Serial Number77239338
Word MarkINVEGA
Filing DateThursday, July 26, 2007
Status800 - REGISTERED AND RENEWED
Status DateWednesday, February 28, 2018
Registration Number3391680
Registration DateTuesday, March 4, 2008
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 18, 2007

Trademark Statements

Description of MarkThe mark consists of, in part, a circle/ring.
Goods and Serviceshuman pharmaceutical for the treatment of Central Nervous System diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 30, 2007
Primary Code005
First Use Anywhere DateWednesday, January 3, 2007
First Use In Commerce DateWednesday, January 3, 2007

Trademark Owner History

Party NameJohnson & Johnson
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 09833
Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001

Trademark Events

Event DateEvent Description
Tuesday, November 13, 2007ASSIGNED TO LIE
Wednesday, November 28, 2007NOTICE OF PUBLICATION
Monday, July 30, 2007NEW APPLICATION ENTERED
Tuesday, July 31, 2007NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, October 9, 2007ASSIGNED TO EXAMINER
Wednesday, October 10, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 13, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 18, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, December 18, 2007PUBLISHED FOR OPPOSITION
Tuesday, March 4, 2008REGISTERED-PRINCIPAL REGISTER
Friday, February 21, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 21, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 24, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 26, 2014TEAS SECTION 8 & 15 RECEIVED
Wednesday, February 26, 2014REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, March 18, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, March 18, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, April 23, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 23, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 23, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 23, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 23, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 28, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, May 20, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 20, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, March 4, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, February 9, 2018TEAS SECTION 8 & 9 RECEIVED
Wednesday, February 28, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, February 28, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, February 28, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Related Keywords

invega system diseases nervous central pharmaceutical treatment human